FUNCTIONS
OF THE LIVER
The
liver plays a major role in the metabolism of glucose and the regulation of
blood glucose concentration. After a meal, glucose is taken up from the portal
venous blood by the liver and con-verted into glycogen, which is stored in the
hepatocytes. Subse-quently, the glycogen is converted back to glucose and
released as needed into the bloodstream to maintain normal levels of blood
glucose. Additional glucose can be synthesized by the liver through a process
called gluconeogenesis. For this process, the liver uses amino acids from
protein breakdown or lactate produced by ex-ercising muscles (Bacon & Di
Bisceglie, 2000).
Use of
amino acids from protein for gluconeogenesis results in the formation of
ammonia as a byproduct. The liver converts this metabolically generated ammonia
into urea. Ammonia produced by bacteria in the intestines is also removed from
portal blood for urea synthesis. In this way, the liver converts ammonia, a
potential toxin, into urea, a compound that can be excreted in the urine.
The
liver also plays an important role in protein metabolism. It synthesizes almost
all of the plasma proteins (except gamma globulin), including albumin, alpha
and beta globulins, blood clotting factors, specific transport proteins, and
most of the plasma lipoproteins. Vitamin K is required by the liver for
syn-thesis of prothrombin and some of the other clotting factors. Amino acids
serve as the building blocks for protein synthesis.
The
liver is also active in fat metabolism. Fatty acids can be bro-ken down for the
production of energy and the production of ke-tone bodies (acetoacetic acid,
beta-hydroxybutyric acid, and acetone). Ketone bodies are small compounds that
can enter the bloodstream and provide a source of energy for muscles and other
tissues. Breakdown of fatty acids into ketone bodies occurs pri-marily when the
availability of glucose for metabolism is limited, as during starvation or in
uncontrolled diabetes. Fatty acids and their metabolic products are also used
for the synthesis of choles-terol, lecithin, lipoproteins, and other complex
lipids. Under some conditions, lipids may accumulate in the hepatocytes,
re-sulting in the abnormal condition called fatty liver.
Vitamins
A, B, and D and several of the B-complex vitamins are stored in large amounts
in the liver. Certain substances, such as iron and copper, are also stored in
the liver. Because the liver is rich in these substances, liver extracts have
been used for therapy for a wide range of nutritional disorders.
The
liver metabolizes many medications, such as barbiturates, opioids, sedative
agents, anesthetics, and amphetamines. Metab-olism generally results in loss of
activity of the medication, although in some cases activation of the medication
may occur. One of the important pathways for medication metabolism in-volves
conjugation (binding) of the medication with a variety of compounds, such as
glucuronic or acetic acid, to form more sol-uble substances. The conjugated
products may be excreted in the feces or urine, similar to bilirubin excretion.
If an oral medication (absorbed from the GI tract) is metabolized by the liver
to a great extent before it reaches the systemic circulation (first-pass effect),
the amount of medication actually reaching the systemic circula-tion (oral
bioavailability) will be decreased. Bioavailability is the fraction of the
administered drug that reaches the systemic circu-lation. Some medications have
such a large first-pass effect that their use is essentially limited to the
parenteral route, or oral doses must be substantially larger than parenteral
doses to achieve the same effect.
Bile
is continuously formed by the hepatocytes and collected in the canaliculi and
bile ducts. It is composed mainly of water and electrolytes such as sodium,
potassium, calcium, chloride, and bi-carbonate, and it also contains
significant amounts of lecithin, fatty acids, cholesterol, bilirubin, and bile
salts. Bile is collected and stored in the gallbladder and is emptied into the
intestine when needed for digestion. The functions of bile are excretory, as in
the excretion of bilirubin; bile also serves as an aid to digestion through the
emulsification of fats by bile salts.
Bile
salts are synthesized by the hepatocytes from cholesterol. After conjugation or
binding with amino acids (taurine and glycine), they are excreted into the
bile. The bile salts, together with cholesterol and lecithin, are required for
emulsification of fats in the intestine, which is necessary for efficient
digestion and absorption. Bile salts are then reabsorbed, primarily in the
distal ileum, into portal blood for return to the liver and are again ex-creted
into the bile. This pathway from hepatocytes to bile to in-testine and back to
the hepatocytes is called the enterohepatic circulation. Because of the
enterohepatic circulation, only a small fraction of the bile salts that enter
the intestine are excreted in the feces. This decreases the need for active
synthesis of bile salts by the liver cells.
Bilirubin
is a pigment derived from the breakdown of hemoglo-bin by cells of the
reticuloendothelial system, including the Kupf-fer cells of the liver.
Hepatocytes remove bilirubin from the blood and chemically modify it through
conjugation to glucuronic acid, which makes the bilirubin more soluble in
aqueous solutions. The conjugated bilirubin is secreted by the hepatocytes into
the adjacent bile canaliculi and is eventually carried in the bile into the
duodenum.
In the
small intestine, bilirubin is converted into urobilino-gen, which is in part
excreted in the feces and in part absorbed through the intestinal mucosa into
the portal blood. Much of this reabsorbed urobilinogen is removed by the
hepatocytes and is se-creted into the bile once again (enterohepatic
circulation). Some of the urobilinogen enters the systemic circulation and is
excreted by the kidneys in the urine. Elimination of bilirubin in the bile
represents the major route of excretion for this compound.
The
bilirubin concentration in the blood may be increased in the presence of liver
disease, when the flow of bile is impeded (ie, with gallstones in the bile
ducts), or with excessive destruc-tion of red blood cells. With bile duct
obstruction, bilirubin does not enter the intestine; as a consequence,
urobilinogen is absent from the urine and decreased in the stool.
The
Gerontologic Considerations Box outlines age-related changes in the liver. The
most common change in the liver in the elderly is a decrease in its size and
weight, accompanied by a decrease in total hepatic blood flow. In general,
however, these decreases are pro-portional to the decreases in body size and
weight seen in normal aging. Results of liver function tests do not normally
change in the elderly; abnormal results in an elderly patient indicate abnormal
liver function and are not the result of the aging process itself.
The
immune system is altered in the aged, and a less respon-sive immune system may
be responsible for the increased inci-dence and severity of hepatitis B in the
elderly and the increased incidence of liver abscesses secondary to decreased
phagocytosis by the Kupffer cells. With the advent of hepatitis B vaccine as
the standard for prevention, the incidence of hepatic diseases may de-crease in
the future.
Metabolism of medications by the liver appears to decrease in the elderly, but such changes are usually accompanied by changes in
intestinal absorption, renal excretion, and altered body distri-bution of some
medications secondary to changes in fat deposition. These alterations
necessitate careful medication administration and monitoring; if appropriate,
reduced dosages may be needed to prevent medication toxicity.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.